UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39

Benzinga Newsdesk www.benzinga.com Neutral 62.4%

Neg 0% Neu 62.4% Pos 0%

UBS analyst Patrick Wood assumes Inspire Medical Systems (NYSE:INSP) with a Sell rating and lowers Price Target of $39.

Comments

No comments yet. Be the first!